News|Articles|February 13, 2019

Yupelri for Chronic Obstructive Pulmonary Disease

Author(s)Drew Boxler

Yupelri (revefenacin, Mylan®)

Indications: Patients with chronic obstructive pulmonary disease

Dosage: One 175 mcg vial (3 mL) once daily.

Contraindications: hypersensitivity to revefenacin or any component of this product.

Click here for more prescribing information


Latest CME